Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Dipeptidyl peptidase-4 (DPP-4) inhibitors are favourable to glucagon-like peptide-1 (GLP-1) agonists: no
Sten Madsbad
Department of Clinical Medicine
14
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dipeptidyl peptidase-4 (DPP-4) inhibitors are favourable to glucagon-like peptide-1 (GLP-1) agonists: no'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Dipeptidyl-Peptidase IV Inhibitors
100%
Glucagon-Like Peptide-1 Receptor
97%
Glucagon-Like Peptide 1
88%
Hypoglycemic Agents
30%
Incretins
14%
Blood Pressure
13%
Weights and Measures
13%
Gastric Emptying
12%
Metformin
11%
Appetite
11%
Glucagon
11%
Insulin Secretion
10%
Hypoglycemia
10%
Nausea
9%
Vomiting
9%
Therapeutics
8%
Psychological Inhibition
8%
Life Style
8%
Insulin
7%
Physicians
6%
Pharmaceutical Preparations
4%